This Special Issue showcases cutting‑edge discoveries in nontuberculous mycobacterial pathogens through biology, infection, and therapeutic innovation. Submit your manuscript by June 30, 2026.
Nontuberculous mycobacteria (NTM) infections have risen steadily in recent years, in some regions surpassing the incidence of new tuberculosis cases and posing an increasingly urgent public health challenge. Species such as Mycobacterium abscessus exhibit extensive intrinsic and acquired antimicrobial resistance, rendering many antibiotic classes ineffective and contributing to persistently low cure rates, chronic disease, and significant mortality. As global NTM prevalence continues to climb, deeper insights into NTM physiology, cell wall biology, host–pathogen interactions, immune responses, and mechanisms of drug resistance are essential to guide the development of innovative therapies, diagnostics, and preventive strategies.
In recognition of this growing threat, ACS Infectious Diseases presents a Special Issue devoted to advancing fundamental and translational research on NTM biology, infection, and treatment, providing a platform for cutting‑edge discoveries that will help shape the next generation of interventions against these resilient pathogens. Read the Call for Papers Editorial to learn more.
Topics include, but are not limited to:
- NTM physiology
- NTM cell wall biology
- Host–pathogen interactions and virulence
- Host immunity
- Drug resistance mechanisms
- Drug discovery
- Anti-NTM drug delivery systems
- NTM treatments and diagnostic markers
- Vaccines
Submit your manuscript by June 30, 2026.
Organizing Editors
Sidharth Chopra, Editorial Advisory Board, ACS Infectious Diseases
CSIR-Central Drug Research Institute, India
Arunava Dasgupta, Guest Editor
CSIR-Central Drug Research Institute, India
Laurent Kremer, Guest Editor
Université de Montpellier, France
Submission Information
We welcome submissions for this Special Issue through June 30, 2026. For more information on submission requirements, please visit the journal’s Author Guidelines page.
Accepted manuscripts for consideration in this Special Issue will include research articles, letters, reviews, perspectives, and viewpoints (perspectives and viewpoints by invitation only). Papers accepted for publication for this Special Issue will be available ASAP (as soon as publishable) online as soon as they are accepted. After all submissions have been published, they will then be compiled online on a dedicated landing page to form the Special Issue. Manuscripts submitted for consideration will undergo the full rigorous peer review process expected from ACS journals.
Open Access: There are diverse open access options for publications in American Chemical Society journals. Please visit our Open Science Resource Center for more information.
How to Submit
- Log in to the ACS Publishing Center.
- Select the "Journals" tab.
- Choose ACS Infectious Diseases.
- Click "Submit."
- Select your manuscript type, and, under "Special Issue Selection," choose “Nontuberculous Mycobacterial (NTM) Pathogens – Biology, Infection, and Drug Discovery."
If you have any general questions regarding submission to this Special Issue, please contact please contact eic@id.acs.org.
Get e-Alerts
Stay Connected With ACS Infectious Diseases
Never miss an issue again! Sign up now for email updates on future calls for papers, the latest articles, and other content from ACS Infectious Diseases.